Navigation Links
Vermillion Announces Return of Eric Fung, M.D., Ph.D.
Date:10/2/2009

FREMONT, Calif., Oct. 2 /PRNewswire-FirstCall/ -- Vermillion, Inc (OTC: VRMLQ.PK) today announced that Eric Fung, M.D., Ph.D., has rejoined the company to become its Chief Science Officer. This position will be formally held by Dr. Fung upon the completion of the Company's restructuring and reorganization under Chapter 11 of the U.S. Bankruptcy Code or earlier, if deemed appropriate by Vermillion's Board of Directors. In the interim, Dr. Fung will work as an independent consultant.

"Dr. Fung was instrumental in the development of the OVA1(TM) test, including biomarker discovery to validation, design and execution of the clinical trial, and submission to the FDA," said Gail Page, Executive Director of the Company. "We are pleased to welcome him back to Vermillion, where he will play a key role in commercialization of the OVA1 test as well as further development of other potential tests in Vermillion's pipeline."

Dr. Fung, age 39, is returning to the company after serving as Director of Clinical Research at Roche Molecular Systems. At Roche, he helped oversee a cervical cancer screening clinical trial involving 45,000 women. Dr. Fung originally joined Vermillion in May 2000 as a lead scientist in the newly formed Biomarker Discovery Centers. He was promoted to Vice President and Chief Scientific Officer in June 2006.

Prior to joining Vermillion, Dr. Fung was a Howard Hughes sponsored researcher at Stanford University. Dr. Fung has anatomic pathology training from Stanford Medical School and obtained his M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine. He graduated with a B.S. with honors from the California Institute of Technology. Dr. Fung has also held an Adjunct Assistant Professor position in the Department of Pathology at the Johns Hopkins University School of Medicine.

About the OVA1 Test

The OVA1 Test is a qualitative serum test that combines the results of f
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 Nuclear reactors are used ... by controlled fission chain reaction in nuclear reactors is ... used to drive a power- generating turbine. Currently nuclear ... world’s total electricity production. Nuclear reactor market is expected ... planned and proposed nuclear reactor projects. , Early buyers ...
(Date:7/22/2014)... CTD Holdings, Inc. (OTCQB:CTDH), a manufacturer and ... and other markets, announced today that it has closed ... private investors led by Novit L.P., an investment arm ... involved the signing of a Securities Purchase Agreement under ... at a price per share of $1.00, resulting in ...
(Date:7/22/2014)... 22, 2014 Automated cell culture systems ... of cell culture. They allow production of optimum cells ... researchers in drug discovery and industries and biopharmaceutical companies. ... production, iPSC research, cryobanking, cell-based assays, and cellular expression ... , Analysts forecast the Global Cell Culture market ...
(Date:7/22/2014)... Rice Lake Weighing Systems ... NCSL International Workshop and Symposium July 28-31 in ... pressure instrumentation, OIML M1 weights, precision lab weights, ... sets, Essential Weights™. , NCSL International was formed ... solving the common problems faced by measurement and ...
Breaking Biology Technology:Nuclear Energy Market: Global Industry Analysis, Size, Share, Analysis, Growth and Forecast 2013 - 2019 2Nuclear Energy Market: Global Industry Analysis, Size, Share, Analysis, Growth and Forecast 2013 - 2019 3CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 4Rice Lake Weighing Systems Showcases Metrology Solutions for the 2014 NCSL International Workshop & Symposium 2
... biotech infrastructure has prompted a Minnesota company to consider ... could employ approximately 200 people. , , Excorp Medical ... Wisconsin to manufacture systems used to treat human liver ... a product that company representatives say has the potential ...
... and growth of the medical device industry and some of ... the leading players in this $100 billion industry. , , ... this table, here are a couple interesting observations: , , ... business (with the exception of the imaging market), which includes ...
... more Wisconsin companies are expected to pitch their businesses ... , ,Eight companies from Wisconsin are now listed as ... will be in Minneapolis. , ,The forum, created ... and the Biotechnology Industry Organization, annually showcases biotech and ...
Cached Biology Technology:Minneapolis company sets sights on southern Wisconsin 2Minneapolis company sets sights on southern Wisconsin 3Midwest plays key role in developing new medical device companies 2Midwest plays key role in developing new medical device companies 3Three more Wisconsin firms to present at venture forum 2
(Date:7/22/2014)... obesity could be on the horizon. Bacteria that ... weight gain, insulin resistance and other adverse effects ... investigators have discovered., "Of course it,s hard to ... Sean Davies, Ph.D., assistant professor of Pharmacology. "But ... of obesity in mice, even though they,re eating ...
(Date:7/22/2014)... the National Institute of Standards and Technology (NIST), ... dramatically improved technique for analyzing biological cells and ... new NIST technique is an advanced form of ... that delivers signals that are 10,000 times stronger ... times stronger than obtained from comparable "coherent Raman" ...
(Date:7/22/2014)... Highly purified crystals that split light with uncanny ... optics and, potentially, computers that manipulate light instead ... techniques, such as etching them with a precise ... expensive. , Now, researchers at Princeton and Columbia ... allow scientists to customize and grow these specialized ...
Breaking Biology News(10 mins):Vanderbilt study shows therapeutic bacteria prevent obesity in mice 2Enhanced NIST instrument enables high-speed chemical imaging of tissues 2Enhanced NIST instrument enables high-speed chemical imaging of tissues 3Technique simplifies the creation of high-tech crystals 2Technique simplifies the creation of high-tech crystals 3
... UK has been given the go-ahead to explore one of ... deep beneath Antarctica,s ice sheet. Buried under 3 km of ... may have been isolated for hundreds of thousands of ... hopes the exploration will yield vital clues about life on ...
... Moose has developed a corn plant with enormous potential for ... Moose said, due to a greater number of leaves and ... crop. The gene known as Glossy 15 was originally ... coating that acts like a sun screen for the young ...
... survey of airborne fungi and fungal spores found in Eastern ... cause of the high incidence of childhood asthma in this ... issue of the International Journal of Environmental Technology and ... human factors that lead to high levels of such fungi. ...
Cached Biology News:Final frontier: Mission to explore buried ancient Antarctic lake given green light 2Doubling a gene in corn results in giant biomass 2Airborne asthma allergens 2
HSD17B3 Immunogen: HSD17B3 (NP_000188, 29 a.a. ~ 120 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rad51, N-terminal...
Phospho-mu-Opioid Receptor (Ser375) Antibody...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Biology Products: